ANO1 is upregulated in a variety of cancers including glioma, colorectal cancer, and HNSCC, but its inhibition has led to decrease in tumor size, cell proliferation, and migration [23,24,25]. This evidence concerns the gene ANO1 and central nervous system cancer.